Viewing Company
Company Name:
DIAMEDICA THERAPEUTICS INC
CIK:
1401040
Phone:
None
Fiscal Year End:
None
Entity Type:
SIC:
-
Category Type:
Entity Name:
None
First Filing Date:
2019-03-19
Last Filing Date:
2025-05-13
SEC Filings
| Start | End | Frame | Filed | ACCN | Value | View |
|---|---|---|---|---|---|---|
| 2022-01-01 | 2022-03-31 | CY2021Q1 | 2022-05-04 | 0001437749-22-010876 | $ 26,443,067 | View |
| 2022-01-01 | 2022-06-30 | CY2022Q2I | 2022-08-11 | 0001437749-22-019848 | $ 2 | View |
| 2022-01-01 | 2022-09-30 | CY2022Q3I | 2022-11-09 | 0001437749-22-026609 | $ 446,000 | View |
| 2019-01-01 | 2019-03-31 | CY2018Q1 | 2019-05-13 | 0001437749-19-009677 | $ 11,956,874 | View |
| 2019-04-01 | 2019-06-30 | CY2018Q2 | 2019-08-13 | 0001437749-19-016595 | $ 11,979,401 | View |
| 2019-07-01 | 2019-09-30 | CY2018Q3 | 2019-11-13 | 0001437749-19-022682 | $ 12,006,874 | View |
| 2019-01-01 | 2019-12-31 | CY2018 | 2020-03-23 | 0001437749-20-005906 | $ 11,987,696 | View |
| 2023-01-01 | 2023-12-31 | CY2023Q4I | 2024-03-19 | 0001437749-24-008522 | $ 17,156 | View |
| 2024-01-01 | 2024-03-31 | CY2024Q1I | 2024-05-08 | 0001437749-24-015381 | $ 150,000 | View |
| 2024-01-01 | 2024-12-31 | CY2024 | 2025-03-17 | 0001437749-25-008018 | $ 34,000 | View |
| 2025-01-01 | 2025-03-31 | CY2025Q1 | 2025-05-13 | 0001437749-25-016488 | $ 1,000 | View |
| 2018-01-01 | 2018-12-31 | CY2017 | 2019-03-19 | 0001437749-19-005272 | $ 7,743,520 | View |
| 2020-01-01 | 2020-03-31 | CY2019Q1 | 2020-05-13 | 0001437749-20-010599 | $ 13,107,725 | View |
| 2020-04-01 | 2020-06-30 | CY2019Q2 | 2020-08-11 | 0001437749-20-017514 | $ 14,139,074 | View |
| 2020-07-01 | 2020-09-30 | CY2019Q3 | 2020-11-04 | 0001437749-20-022537 | $ 16,689,074 | View |
| 2020-01-01 | 2020-12-31 | CY2019 | 2021-03-10 | 0001437749-21-005541 | $ 15,680,320 | View |
| 2021-01-01 | 2021-03-31 | CY2021Q1 | 2021-05-05 | 0001437749-21-010912 | $ 18,766,656 | View |
| 2021-04-01 | 2021-06-30 | CY2021Q2 | 2021-08-11 | 0001437749-21-019480 | $ 18,786,157 | View |
| 2021-07-01 | 2021-09-30 | CY2021Q3 | 2021-11-10 | 0001437749-21-026175 | $ 19,035,713 | View |
| 2021-01-01 | 2021-12-31 | CY2020Q4I | 2022-03-14 | 0001437749-22-006163 | $ 0 | View |
| 2022-01-01 | 2022-12-31 | CY2021Q4I | 2023-03-28 | 0001437749-23-008189 | $ 42,000 | View |
| 2023-01-01 | 2023-03-31 | CY2023Q1I | 2023-05-15 | 0001437749-23-014616 | $ 0 | View |
| 2023-04-01 | 2023-06-30 | CY2023Q2I | 2023-08-14 | 0001437749-23-023708 | $ 20,296,000 | View |
| 2023-07-01 | 2023-09-30 | CY2023Q3I | 2023-11-13 | 0001437749-23-031671 | $ 9,746,000 | View |
| 2024-04-01 | 2024-06-30 | CY2024Q2I | 2024-08-07 | 0001437749-24-025198 | $ 155,000 | View |
| 2024-07-01 | 2024-09-30 | CY2024Q3I | 2024-11-13 | 0001437749-24-034925 | $ 91,000 | View |
SEC Facts By Type
| Type | Name | Description | View |
|---|---|---|---|
| us-gaap | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. | View |
| us-gaap | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. | View |
| us-gaap | Capital Lease Obligations, Noncurrent | Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date. | View |
| us-gaap | Cash, Cash Equivalents, and Short-term Investments | Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable. | View |
| us-gaap | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | View |
| us-gaap | Derivative Liability, Current | Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. | View |
| us-gaap | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. | View |
| us-gaap | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement. | View |
| us-gaap | Investment Income, Net, Amortization of Discount and Premium | Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities. | View |
| us-gaap | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. | View |
| us-gaap | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. | View |
| us-gaap | Research and Development Expense | The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | View |
| us-gaap | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. | View |
| us-gaap | Number of Operating Segments | Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. | View |
| us-gaap | Other Nonoperating Expense | Amount of expense related to nonoperating activities, classified as other. | View |
| us-gaap | Fair Value of Assets Acquired | The fair value of assets acquired in noncash investing or financing activities. | View |
| us-gaap | Finance Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from finance lease, classified as current. | View |
| us-gaap | Finance Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent. | View |
| us-gaap | Finance Lease, Principal Payments | Amount of cash outflow for principal payment on finance lease. | View |
| dei | Entity Common Stock, Shares Outstanding | Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. | View |
| dei | Entity Public Float | The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. | View |
| us-gaap | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. | View |
| us-gaap | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accounts Payable, Trade, Current | Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. | View |
| us-gaap | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services. | View |
| us-gaap | Additional Paid in Capital | Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. | View |
| us-gaap | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. | View |
| us-gaap | Share-based Payment Arrangement, Expense | Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. | View |
| us-gaap | Assets | Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Assets, Current | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Assets, Noncurrent | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. | View |
| us-gaap | Capital Lease Obligations, Current | Amount of capital lease obligation due within one year or the normal operating cycle, if longer. | View |
| us-gaap | Cash | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Cash and Cash Equivalents, Period Increase (Decrease) | Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Common Stock, Capital Shares Reserved for Future Issuance | Aggregate number of common shares reserved for future issuance. | View |
| us-gaap | Common Stock, No Par Value | Face amount per share of no-par value common stock. | View |
| us-gaap | Investment Income, Amortization of Discount | Amount of accretion of purchase discount on nonoperating securities. | View |
| us-gaap | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | View |
| us-gaap | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. | View |
| us-gaap | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. | View |
| us-gaap | Deferred Tax Assets, in Process Research and Development | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. | View |
| us-gaap | Deferred Tax Assets, Net of Valuation Allowance | Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. | View |
| us-gaap | Deferred Tax Assets, Property, Plant and Equipment | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment. | View |
| us-gaap | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals. | View |
| us-gaap | Deferred Tax Assets, Valuation Allowance | Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. | View |
| us-gaap | Deferred Tax Liabilities, Deferred Expense | Amount of deferred tax liability attributable to taxable temporary differences from capitalized costs. | View |
| us-gaap | Deferred Tax Liabilities, Property, Plant and Equipment | Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment. | View |
| us-gaap | Defined Contribution Plan, Employer Discretionary Contribution Amount | Amount of discretionary contributions made by an employer to a defined contribution plan. | View |
| us-gaap | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | Percentage employer matches of the employee's percentage contribution matched. | View |
| us-gaap | Deposits Assets, Current | Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter. | View |
| us-gaap | Deposits Assets, Noncurrent | Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer. | View |
| us-gaap | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. | View |
| us-gaap | Earnings Per Share, Basic and Diluted | The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | Percentage of domestic federal statutory tax rate applicable to pretax income (loss). | View |
| us-gaap | Employee-related Liabilities, Current | Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | Amount of cost to be recognized for option under share-based payment arrangement. | View |
| us-gaap | Fair Value Adjustment of Warrants | Amount of expense (income) related to adjustment to fair value of warrant liability. | View |
| us-gaap | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | View |
| us-gaap | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. | View |
| us-gaap | Income Taxes Paid | The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income. | View |
| us-gaap | Income Taxes Receivable, Current | Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit). | View |
| us-gaap | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. | View |
| us-gaap | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. | View |
| us-gaap | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. | View |
| us-gaap | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. | View |
| us-gaap | Increase (Decrease) in Deposit Assets | The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits. | View |
| us-gaap | Increase (Decrease) in Prepaid Expense | The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. | View |
| us-gaap | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. | View |
| us-gaap | Interest Receivable, Current | Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer. | View |
| us-gaap | Lessee, Operating Lease, Discount Rate | Discount rate used by lessee to determine present value of operating lease payments. | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid | Amount of lessee's undiscounted obligation for lease payment for operating lease. | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid, Year One | Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid, Year Four | Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid, Year Three | Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid, Year Two | Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year. | View |
| us-gaap | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease. | View |
| us-gaap | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. | View |
| us-gaap | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. | View |
| us-gaap | Liabilities, Noncurrent | Amount of obligation due after one year or beyond the normal operating cycle, if longer. | View |
| us-gaap | Marketable Securities | Amount of investment in marketable security. | View |
| us-gaap | Marketable Securities, Current | Amount of investment in marketable security, classified as current. | View |
| us-gaap | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. | View |
| us-gaap | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | View |
| us-gaap | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | View |
| us-gaap | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). | View |
| us-gaap | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. | View |
| us-gaap | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. | View |
| us-gaap | Operating Lease, Cost | Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability. | View |
| us-gaap | Operating Lease, Liability | Present value of lessee's discounted obligation for lease payments from operating lease. | View |
| us-gaap | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. | View |
| us-gaap | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. | View |
| us-gaap | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. | View |
| us-gaap | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. | View |
| us-gaap | Other Receivables | Amount due from parties in nontrade transactions, classified as other. | View |
| us-gaap | Payments for (Proceeds from) Productive Assets | The net cash outflow or inflow from purchases, sales and disposals of property, plant and equipment and other productive assets, including intangibles. | View |
| us-gaap | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. | View |
| us-gaap | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. | View |
| us-gaap | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. | View |
| us-gaap | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. | View |
| us-gaap | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. | View |
| us-gaap | Proceeds from Issuance of Private Placement | The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. | View |
| us-gaap | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Proceeds from Sale of Property, Plant, and Equipment | The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. | View |
| us-gaap | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. | View |
| us-gaap | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. | View |
| us-gaap | Property, Plant and Equipment, Disposals | Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment. | View |
| us-gaap | Property, Plant and Equipment, Gross | Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. | View |
| us-gaap | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | View |
| us-gaap | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. | View |
| us-gaap | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. | View |
| us-gaap | Variable Lease, Cost | Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases. | View |
| us-gaap | Warrants and Rights Outstanding | Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic and Diluted | Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). | View |
| us-gaap | Deferred Tax Assets, Net | Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. | View |
| us-gaap | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | View |
| us-gaap | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | Amount of increase in right-of-use asset obtained in exchange for finance lease liability. | View |
| us-gaap | Retained Earnings (Accumulated Deficit) | The cumulative amount of the reporting entity's undistributed earnings or deficit. | View |
| us-gaap | Revenue from Contract with Customer, Including Assessed Tax | Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. | View |
| us-gaap | Share-based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | The risk-free interest rate assumption that is used in valuing an option on its own shares. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Gross number of share options (or share units) granted during the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. | View |
| us-gaap | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable | The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. | View |
| us-gaap | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding | The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | Number of non-vested options outstanding. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares | Number of non-vested options forfeited. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value | Weighted average grant-date fair value of non-vested options forfeited. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | Weighted average grant-date fair value of non-vested options outstanding. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | Number of options vested. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | Weighted average grant-date fair value of options vested. | View |
| us-gaap | Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price | The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices. | View |
| us-gaap | Shares Issued, Price Per Share | Per share or per unit amount of equity securities issued. | View |
| us-gaap | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). | View |
| us-gaap | Stockholders' Equity Attributable to Parent | Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. | View |
| us-gaap | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | View |
| us-gaap | Interest Payable, Current | Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Number of options outstanding, including both vested and non-vested options. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | Weighted average price at which option holders acquired shares when converting their stock options into shares. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid, Year Five | Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | Amount of increase in right-of-use asset obtained in exchange for operating lease liability. | View |
| us-gaap | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. | View |
| us-gaap | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | View |
| us-gaap | Prepaid Supplies | Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer. | View |
| us-gaap | Debt Securities, Available-for-sale | Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited. | View |
| us-gaap | Marketable Securities, Noncurrent | Amount of investment in marketable security, classified as noncurrent. | View |
| us-gaap | Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures | Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited. | View |
| us-gaap | Accrued Professional Fees, Current | Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
Chart of Accounts => Accounts
| Name | View |
|---|---|
| Defined Contribution Plan, Employer Matching Contribution, Percent of Match | View |
| Income Taxes Receivable, Current | View |
| Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | View |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount | View |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | View |
| Payments to Acquire Property, Plant, and Equipment | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | View |
| Investment Income, Interest | View |
| Number of Operating Segments | View |
| Other Nonoperating Expense | View |
| Accounts Payable and Accrued Liabilities, Current | View |
| Accounts Payable, Current | View |
| Accounts Payable, Trade, Current | View |
| Accounts Receivable, after Allowance for Credit Loss, Current | View |
| Accrued Liabilities, Current | View |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | View |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | View |
| Additional Paid in Capital | View |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | View |
| Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | View |
| Share-based Payment Arrangement, Expense | View |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | View |
| Assets | View |
| Assets, Current | View |
| Assets, Noncurrent | View |
| Capital Lease Obligations, Current | View |
| Capital Lease Obligations, Noncurrent | View |
| Cash | View |
| Cash and Cash Equivalents, at Carrying Value | View |
| Cash and Cash Equivalents, Period Increase (Decrease) | View |
| Cash, Cash Equivalents, and Short-term Investments | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | View |
| Common Stock, Capital Shares Reserved for Future Issuance | View |
| Common Stock, No Par Value | View |
| Common Stock, Shares, Issued | View |
| Common Stock, Shares, Outstanding | View |
| Common Stock, Value, Issued | View |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | View |
| Deferred Tax Assets, in Process Research and Development | View |
| Deferred Tax Assets, Net of Valuation Allowance | View |
| Deferred Tax Assets, Operating Loss Carryforwards | View |
| Deferred Tax Assets, Property, Plant and Equipment | View |
| Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | View |
| Deferred Tax Assets, Valuation Allowance | View |
| Deferred Tax Liabilities, Deferred Expense | View |
| Deferred Tax Liabilities, Property, Plant and Equipment | View |
| Defined Contribution Plan, Employer Discretionary Contribution Amount | View |
| Deposits Assets, Current | View |
| Deposits Assets, Noncurrent | View |
| Depreciation | View |
| Derivative Liability, Current | View |
| Earnings Per Share, Basic and Diluted | View |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | View |
| Employee-related Liabilities, Current | View |
| Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | View |
| Fair Value Adjustment of Warrants | View |
| Fair Value of Assets Acquired | View |
| Finance Lease, Liability, Current | View |
| Finance Lease, Liability, Noncurrent | View |
| Finance Lease, Principal Payments | View |
| General and Administrative Expense | View |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | View |
| Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | View |
| Income Tax Expense (Benefit) | View |
| Income Taxes Paid | View |
| Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount | View |
| Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount | View |
| Increase (Decrease) in Accounts Payable | View |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | View |
| Increase (Decrease) in Accounts Receivable | View |
| Increase (Decrease) in Accrued Liabilities | View |
| Increase (Decrease) in Deposit Assets | View |
| Increase (Decrease) in Prepaid Expense | View |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | View |
| Interest Receivable, Current | View |
| Investment Income, Amortization of Discount | View |
| Investment Income, Net, Amortization of Discount and Premium | View |
| Lessee, Operating Lease, Discount Rate | View |
| Lessee, Operating Lease, Liability, to be Paid | View |
| Lessee, Operating Lease, Liability, to be Paid, Year One | View |
| Lessee, Operating Lease, Liability, to be Paid, Year Four | View |
| Lessee, Operating Lease, Liability, to be Paid, Year Three | View |
| Lessee, Operating Lease, Liability, to be Paid, Year Two | View |
| Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | View |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount | View |
| Liabilities and Equity | View |
| Liabilities, Current | View |
| Liabilities, Noncurrent | View |
| Marketable Securities | View |
| Marketable Securities, Current | View |
| Net Cash Provided by (Used in) Financing Activities | View |
| Net Cash Provided by (Used in) Investing Activities | View |
| Net Cash Provided by (Used in) Operating Activities | View |
| Net Income (Loss) Attributable to Parent | View |
| Nonoperating Income (Expense) | View |
| Operating Expenses | View |
| Operating Income (Loss) | View |
| Operating Lease, Cost | View |
| Operating Lease, Liability | View |
| Operating Lease, Liability, Current | View |
| Operating Lease, Liability, Noncurrent | View |
| Operating Lease, Right-of-Use Asset | View |
| OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | View |
| Other Nonoperating Income (Expense) | View |
| Other Receivables | View |
| Payments for (Proceeds from) Productive Assets | View |
| Payments to Acquire Marketable Securities | View |
| Prepaid Expense and Other Assets, Current | View |
| Prepaid Expense, Current | View |
| Proceeds from Issuance of Common Stock | View |
| Proceeds from Issuance of Private Placement | View |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | View |
| Proceeds from Sale of Property, Plant, and Equipment | View |
| Proceeds from Stock Options Exercised | View |
| Proceeds from Warrant Exercises | View |
| Property, Plant and Equipment, Disposals | View |
| Property, Plant and Equipment, Gross | View |
| Property, Plant and Equipment, Net | View |
| Research and Development Expense | View |
| Retained Earnings (Accumulated Deficit) | View |
| Revenue from Contract with Customer, Including Assessed Tax | View |
| Share-based Payment Arrangement, Noncash Expense | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | View |
| Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable | View |
| Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | View |
| Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price | View |
| Shares Issued, Price Per Share | View |
| Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture | View |
| Stockholders' Equity Attributable to Parent | View |
| Stock Issued During Period, Shares, New Issues | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | View |
| Stock Issued During Period, Value, New Issues | View |
| Stock Issued During Period, Value, Stock Options Exercised | View |
| Variable Lease, Cost | View |
| Warrants and Rights Outstanding | View |
| Weighted Average Number of Shares Outstanding, Basic and Diluted | View |
| Deferred Tax Assets, Net | View |
| Earnings Per Share, Basic | View |
| Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | View |
| Weighted Average Number of Shares Outstanding, Basic | View |
| Interest Payable, Current | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | View |
| Lessee, Operating Lease, Liability, to be Paid, Year Five | View |
| Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | View |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | View |
| Shares, Outstanding | View |
| Prepaid Supplies | View |
| Debt Securities, Available-for-sale | View |
| Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | View |
| Marketable Securities, Noncurrent | View |
| Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures | View |
| Accrued Professional Fees, Current | View |